<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Applied Spectral Imaging 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=24735></link><description><![CDATA[Applied Spectral Imaging 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Fri, 15 May 2026 01:33:28 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2015/04/3554153577_20150420150837_5568552388.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Applied Spectral Imaging Received South Korean Ministry of Food and Drug Safety (MFDS) Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67]]></title><link>https://www.newswire.co.kr/newsRead.php?no=789369</link><description><![CDATA[CARLSBAD, Calif.--(Business Wire/Korea Newswire)--Applied Spectral Imaging (ASI, ) announced today that it has received clearance from the South Korean Ministry of Food and Drug Safety (MFDS) for its GenASIs HiPath image capture and analysis platform. The South Korean market is a key market for ASI’s computer-aided imaging solutions for pathology, which help improve patient care. “We are lookin...]]></description><pubDate>Mon, 20 Apr 2015 15:20:00 +0900</pubDate></item><item><title><![CDATA[Applied Spectral Imaging, GenASIs™ HiPath 대한민국 식품의약품안전처 승인 획득…HER2/ER/PR/Ki67 진단 지원]]></title><link>https://www.newswire.co.kr/newsRead.php?no=789370</link><description><![CDATA[칼즈배드, 캘리포니아--(Business Wire/뉴스와이어)--Applied Spectral Imaging (이하 ASI)이 자사의 이미지 촬영 및 분석 플랫폼인 ‘GenASIs 하이패스’(GenASIs HiPath)’가 대한민국 식품의약품안전처(MFDS)의 승인을 획득했다고 오늘 발표했다. 한국은 환자 진료 향상에 도움을 주는 ASI의 병리진단용 컴퓨터 이미징 솔루션의 주요 시장이다. 리모 쉬포시(Limor Shiposh) ASI 최고경영자(CEO)는 “이 중요한 승인을 발판으로 ...]]></description><pubDate>Mon, 20 Apr 2015 15:20:00 +0900</pubDate></item></channel></rss>